Herein, we demonstrate that cancer cell stemness, as measured by increased expression of the pluripotency-associated transcription factors Sox2, Nanog, and Oct4, appears to be required for the maintenance and potentiation of the myCAF phenotype. The gene discussed is SOX2; the disease is cancer.